Disseminated Herpes Zoster in a COVID-19 Patient

Safoura Shakoei; Raana Samiei; Sedigheh Hantoushzadeh; Shahin Hamzelou

doi:10.18502/jimc.v5i2.10474

Safoura Shakoei Department of Dermatology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
Raana Samiei Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
Sedigheh Hantoushzadeh Department of Obstetrics and Gynecology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
Shahin Hamzelou Department of Dermatology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran

DOI: https://doi.org/10.18502/jimc.v5i2.10474

Keywords: COVID-19, Herpes zoster, Shingles

Abstract

COVID-19 has several different presentations including cutaneous manifestations. In this report, we introduce a case of generalized herpes zoster in a COVID-19 patient. No sign of upper or lower respiratory tract involvement was detected, but due to unexpected dissemination of the lesions, COVID-19 Polymerase Chain Reaction (PCR) was tested and revealed positive. Although the incidence of herpes zoster during COVID-19 infection has been reported previously, none of them was disseminated. Therefore, we recommend that during the pandemic of COVID-19, any unexpected disseminated herpes zoster be considered as a possible case of this disease and be quarantined until the PCR is negative.